Upgrade to SI Premium - Free Trial

Arbutus Biopharma (ABUS)

4.21 -0.07 (1.64%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/11/26)

Latest Headlines

Form SCHEDULE 13G/A Arbutus Biopharma Corp Filed by: BlackRock, Inc. October 27, 2026 5:26 PM - SEC Filing FDA lifts clinical hold on Arbutus Biopharma's AB-101 drug candidate October 22, 2026 7:31 AM - StreetInsider Form 8-K Arbutus Biopharma Corp For: Oct 20 October 22, 2026 7:31 AM - SEC Filing Arbutus Announces FDA Clinical Hold is Lifted on IND Application for AB-101, an Oral PD-L1 Inhibitor October 22, 2026 7:30 AM - StreetInsider Form SCHEDULE 13G/A Arbutus Biopharma Corp Filed by: MORGAN STANLEY October 7, 2026 4:35 PM - SEC Filing Form 4 Arbutus Biopharma Corp For: Oct 01 Filed by: Beardsley Robert A October 7, 2026 4:12 PM - SEC Filing Form 4 Arbutus Biopharma Corp For: Oct 01 Filed by: Nguyen Tuan October 7, 2026 4:12 PM - SEC Filing Form 4 Arbutus Biopharma Corp For: Oct 01 Filed by: Sawhney Roger October 7, 2026 4:10 PM - SEC Filing Form 4 Arbutus Biopharma Corp For: Oct 01 Filed by: Androski Lindsay October 7, 2026 4:09 PM - SEC Filing Increasing unusual option volume: ABUS PACB DNA GMAB TWST HHH October 7, 2026 6:13 AM - StreetInsider Form SCHEDULE 13D/A Arbutus Biopharma Corp Filed by: Roivant Sciences Ltd. October 5, 2026 9:02 PM - SEC Filing Form 4 Arbutus Biopharma Corp For: Oct 01 Filed by: Roivant Sciences Ltd. October 5, 2026 9:00 PM - SEC Filing Form SC TO-I/A Arbutus Biopharma Corp Filed by: Arbutus Biopharma Corp October 1, 2026 7:36 AM - SEC Filing Arbutus Announces Final Results of Its US$230 Million Modified “Dutch Auction” Tender Offer October 1, 2026 7:30 AM - StreetInsider Form SC TO-I/A Arbutus Biopharma Corp Filed by: Arbutus Biopharma Corp September 30, 2026 7:36 AM - SEC Filing Arbutus Announces Preliminary Results of Its US$230 Million Modified “Dutch Auction” Tender Offer September 30, 2026 7:30 AM - StreetInsider Increasing unusual option volume: ABUS KOD FHN GRAL ACAD XIFR GXO ADMA PACS September 29, 2026 5:46 AM - StreetInsider Increasing unusual call option volume: ERAS ABUS SGHC AKAM XLU KOD ACMR BBD September 28, 2026 5:49 AM - StreetInsider Increasing unusual option volume: ABUS GFL OI GETY RNG FEZ ERIC September 24, 2026 6:14 AM - StreetInsider Form 4 Arbutus Biopharma Corp For: Sep 18 Filed by: Androski Lindsay September 23, 2026 8:32 PM - SEC Filing Form 4 Arbutus Biopharma Corp For: Sep 18 Filed by: Nguyen Tuan September 23, 2026 8:32 PM - SEC Filing Form 4 Arbutus Biopharma Corp For: Sep 18 Filed by: Sawhney Roger September 23, 2026 8:31 PM - SEC Filing Form 4 Arbutus Biopharma Corp For: Sep 18 Filed by: Beardsley Robert A September 23, 2026 8:31 PM - SEC Filing Increasing unusual option volume: ABUS NICE GFL KOD CGON GLAS EWG September 23, 2026 6:22 AM - StreetInsider Form SC TO-I Arbutus Biopharma Corp Filed by: Arbutus Biopharma Corp August 24, 2026 8:24 AM - SEC Filing Arbutus Biopharma launches $230M Dutch auction tender offer August 24, 2026 7:30 AM - StreetInsider Arbutus Commences US$230 Million Modified “Dutch Auction” Tender Offer of its Common Shares at a Price Not Greater Than US$5.75 Nor Less Than US$5.00 Per Share August 24, 2026 7:30 AM - StreetInsider Form SC TO-C Arbutus Biopharma Corp Filed by: Arbutus Biopharma Corp August 21, 2026 8:04 AM - SEC Filing Form 8-K Arbutus Biopharma Corp For: Aug 21 August 21, 2026 7:53 AM - SEC Filing Arbutus plans $230M share repurchase via Dutch auction tender offer August 21, 2026 7:30 AM - StreetInsider Arbutus Announces Intent to Repurchase Up to US$230 Million of its Common Shares Through Modified “Dutch Auction” Tender Offer August 21, 2026 7:30 AM - StreetInsider Form SCHEDULE 13G/A Arbutus Biopharma Corp Filed by: MORGAN STANLEY August 12, 2026 3:02 PM - SEC Filing Arbutus Biopharma (ABUS) Reports In-Line Q2 EPS August 12, 2026 7:50 AM - StreetInsider Form 10-Q Arbutus Biopharma Corp For: Jun 30 August 12, 2026 7:32 AM - SEC Filing Form 8-K Arbutus Biopharma Corp For: Aug 12 August 12, 2026 7:31 AM - SEC Filing Arbutus Reports Second Quarter 2026 Financial Results and Provides Corporate Update August 12, 2026 7:30 AM - StreetInsider Full Article List